FDG-PET in radiotherapy treatment planning: Pandora's box?

International Journal of Radiation Oncology Biology Physics

Volumn 59, Issue 1, 2004, Pages 4-5

  Paulino, Arnold C ^a   Johnstone, Peter A S ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

CANCER CONTROL; CANCER RADIOTHERAPY; CANCER SIZE; DIAGNOSTIC PROCEDURE; EDITORIAL; HEAD CANCER; HUMAN; LUNG NON SMALL CELL CANCER; LYMPHOMA; MEDICAL SPECIALIST; NECK CANCER; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIATION DOSE; TREATMENT OUTCOME; TREATMENT PLANNING;

CARCINOMA, NON-SMALL-CELL LUNG; FLUORODEOXYGLUCOSE F18; HUMANS; LUNG NEOPLASMS; RADIATION ONCOLOGY; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 16344364167     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2003.10.045     Document Type: Editorial

References (12)

1. Lardinois D., Weder W., Hany T.F., et al. Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography. N Engl J Med. 348:2003;2500-2507.
2. MacManus M.P., Hicks R.J., Matthews J.P., et al. Positron emission tomography is superior to computed tomography scanning for response-assessment after radical radiotherapy or chemoradiotherapy in patients with non-small cell lung cancer. J Clin Oncol. 21:2003;1285-1292.
3. Bradley J, Thorstad WL, Mutic S, et al. Impact of FDG-PET on radiation therapy volume delineation in non-small cell lung cancer. Int J Radiat Oncol Biol Phys 2004;59:78-86.
4. Erdi Y.E., Rosenweig K., Erdi A.K., et al. Radiotherapy treatment planning for patients with non-small cell lung cancer using positron emission tomography (PET). Radiother Oncol. 62:2002;51-60.
5. 18F fluorodeoxyglucose positron emission tomography in patients with non-small cell lung cancer A prospective study. J Clin Oncol. 19:2001;111-118.
6. 18F-fluoro-2-deoxy-glucose positron emission tomographic imaging to radiotherapy planning in lung cancer. Lung Cancer. 19:1998;167-177.
7. 18FDG-PET on target and critical organs in CT-based treatment planning of patients with poorly defined non-small cell lung carcinoma A prospective study. Int J Radiat Oncol Biol Phys. 52:2002;339-350.
8. 18F-deoxyglucose positron emission tomography (FDG-PET) for the planning of radiotherapy in lung cancer High impact in patients with atelectasis. Int J Radiat Oncol Biol Phys. 44:1999;593-597.
9. 18F-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) lymph node staging on the radiation treatment volumes in patients with non-small cell lung cancer. Radiother Oncol. 55:2000;317-324.
10. Paulino A.C., Thorstad W.L., Fox T. Role of fusion in radiotherapy treatment planning. Semin Nucl Med. 33:2003;238-243.
11. American Society for Therapeutic Radiology and Oncology Consensus Panel Guidelines for PSA following radiation therapy. Int J Radiat Oncol Biol Phys 1997;37:1035.
12. Feinstein A.R., Sosin D.M., Wells C.K. The Will Rogers Phenomenon Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med. 312:1985;1604-1608.